CN108025110B - 可注射大孔水凝胶 - Google Patents
可注射大孔水凝胶 Download PDFInfo
- Publication number
- CN108025110B CN108025110B CN201680051583.8A CN201680051583A CN108025110B CN 108025110 B CN108025110 B CN 108025110B CN 201680051583 A CN201680051583 A CN 201680051583A CN 108025110 B CN108025110 B CN 108025110B
- Authority
- CN
- China
- Prior art keywords
- polymer
- peg
- mol
- oxazoline
- polyethylene glycol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/20—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/18—Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
- A61L27/227—Other specific proteins or polypeptides not covered by A61L27/222, A61L27/225 or A61L27/24
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/26—Mixtures of macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
- A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/52—Hydrogels or hydrocolloids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/56—Porous materials, e.g. foams or sponges
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
- C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
- C08G65/32—Polymers modified by chemical after-treatment
- C08G65/329—Polymers modified by chemical after-treatment with organic compounds
- C08G65/331—Polymers modified by chemical after-treatment with organic compounds containing oxygen
- C08G65/332—Polymers modified by chemical after-treatment with organic compounds containing oxygen containing carboxyl groups, or halides, or esters thereof
- C08G65/3322—Polymers modified by chemical after-treatment with organic compounds containing oxygen containing carboxyl groups, or halides, or esters thereof acyclic
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J3/00—Processes of treating or compounding macromolecular substances
- C08J3/02—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques
- C08J3/03—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques in aqueous media
- C08J3/075—Macromolecular gels
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J9/00—Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof
- C08J9/28—Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof by elimination of a liquid phase from a macromolecular composition or article, e.g. drying of coagulum
- C08J9/286—Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof by elimination of a liquid phase from a macromolecular composition or article, e.g. drying of coagulum the liquid phase being a solvent for the monomers but not for the resulting macromolecular composition, i.e. macroporous or macroreticular polymers
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
- C08L5/02—Dextran; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
- C08L5/08—Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L53/00—Compositions of block copolymers containing at least one sequence of a polymer obtained by reactions only involving carbon-to-carbon unsaturated bonds; Compositions of derivatives of such polymers
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L71/00—Compositions of polyethers obtained by reactions forming an ether link in the main chain; Compositions of derivatives of such polymers
- C08L71/02—Polyalkylene oxides
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L71/00—Compositions of polyethers obtained by reactions forming an ether link in the main chain; Compositions of derivatives of such polymers
- C08L71/08—Polyethers derived from hydroxy compounds or from their metallic derivatives
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L79/00—Compositions of macromolecular compounds obtained by reactions forming in the main chain of the macromolecule a linkage containing nitrogen with or without oxygen or carbon only, not provided for in groups C08L61/00 - C08L77/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2400/00—Materials characterised by their function or physical properties
- A61L2400/06—Flowable or injectable implant compositions
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2371/00—Characterised by the use of polyethers obtained by reactions forming an ether link in the main chain; Derivatives of such polymers
- C08J2371/02—Polyalkylene oxides
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2405/00—Characterised by the use of polysaccharides or of their derivatives not provided for in groups C08J2401/00 or C08J2403/00
- C08J2405/02—Dextran; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2405/00—Characterised by the use of polysaccharides or of their derivatives not provided for in groups C08J2401/00 or C08J2403/00
- C08J2405/08—Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L2201/00—Properties
- C08L2201/54—Aqueous solutions or dispersions
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Transplantation (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Polymers & Plastics (AREA)
- General Chemical & Material Sciences (AREA)
- Dispersion Chemistry (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Neurology (AREA)
- Materials Engineering (AREA)
- Zoology (AREA)
- Botany (AREA)
- Urology & Nephrology (AREA)
- Cell Biology (AREA)
- Heart & Thoracic Surgery (AREA)
- Neurosurgery (AREA)
- Cardiology (AREA)
- Rheumatology (AREA)
- Medicinal Preparation (AREA)
- Materials For Medical Uses (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110629796.7A CN113372579B (zh) | 2015-09-09 | 2016-09-08 | 可注射大孔水凝胶 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP15184552.6 | 2015-09-09 | ||
| EP15184552 | 2015-09-09 | ||
| PCT/EP2016/071238 WO2017042301A1 (en) | 2015-09-09 | 2016-09-08 | Injectable macroporous hydrogels |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202110629796.7A Division CN113372579B (zh) | 2015-09-09 | 2016-09-08 | 可注射大孔水凝胶 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN108025110A CN108025110A (zh) | 2018-05-11 |
| CN108025110B true CN108025110B (zh) | 2021-08-20 |
Family
ID=54150245
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201680051583.8A Active CN108025110B (zh) | 2015-09-09 | 2016-09-08 | 可注射大孔水凝胶 |
| CN202110629796.7A Active CN113372579B (zh) | 2015-09-09 | 2016-09-08 | 可注射大孔水凝胶 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202110629796.7A Active CN113372579B (zh) | 2015-09-09 | 2016-09-08 | 可注射大孔水凝胶 |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US20180264176A1 (enExample) |
| EP (2) | EP3868416B1 (enExample) |
| JP (1) | JP6829898B2 (enExample) |
| CN (2) | CN108025110B (enExample) |
| AU (1) | AU2016320395B2 (enExample) |
| CA (1) | CA2992692C (enExample) |
| CY (1) | CY1124571T1 (enExample) |
| DK (2) | DK3347061T3 (enExample) |
| ES (1) | ES2883235T3 (enExample) |
| HR (1) | HRP20211306T1 (enExample) |
| HU (1) | HUE055937T2 (enExample) |
| IL (1) | IL257024B (enExample) |
| LT (1) | LT3347061T (enExample) |
| PL (1) | PL3347061T3 (enExample) |
| PT (1) | PT3347061T (enExample) |
| RS (1) | RS62239B1 (enExample) |
| SI (1) | SI3347061T1 (enExample) |
| SM (1) | SMT202100470T1 (enExample) |
| WO (1) | WO2017042301A1 (enExample) |
Families Citing this family (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3064403C (en) | 2010-10-01 | 2022-06-21 | Applied Medical Resources Corporation | Portable laparoscopic trainer |
| KR101963610B1 (ko) | 2011-10-21 | 2019-03-29 | 어플라이드 메디컬 리소시스 코포레이션 | 수술 트레이닝용 모의 조직 구조 |
| JP2015503961A (ja) | 2011-12-20 | 2015-02-05 | アプライド メディカル リソーシーズ コーポレイション | 高度手術シミュレーション |
| JP2015532450A (ja) | 2012-09-26 | 2015-11-09 | アプライド メディカル リソーシーズ コーポレイション | 腹腔鏡処置のための外科訓練モデル |
| US10679520B2 (en) | 2012-09-27 | 2020-06-09 | Applied Medical Resources Corporation | Surgical training model for laparoscopic procedures |
| WO2014052612A1 (en) | 2012-09-27 | 2014-04-03 | Applied Medical Resources Corporation | Surgical training model for laparoscopic procedures |
| US9940849B2 (en) | 2013-03-01 | 2018-04-10 | Applied Medical Resources Corporation | Advanced surgical simulation constructions and methods |
| ES2946968T3 (es) | 2013-06-18 | 2023-07-28 | Applied Med Resources | Modelo de vesícula biliar |
| CA2916952C (en) | 2013-07-24 | 2023-10-17 | Applied Medical Resources Corporation | First entry model for practicing first entry surgical procedures |
| US10198966B2 (en) | 2013-07-24 | 2019-02-05 | Applied Medical Resources Corporation | Advanced first entry model for surgical simulation |
| KR102438168B1 (ko) | 2014-03-26 | 2022-08-31 | 어플라이드 메디컬 리소시스 코포레이션 | 시뮬레이션된 절개가능 조직 |
| KR20240154096A (ko) | 2014-11-13 | 2024-10-24 | 어플라이드 메디컬 리소시스 코포레이션 | 시뮬레이션된 조직 모델들 및 방법들 |
| KR102438169B1 (ko) | 2015-02-19 | 2022-08-31 | 어플라이드 메디컬 리소시스 코포레이션 | 시뮬레이션된 조직 구조체들 및 방법들 |
| WO2016183412A1 (en) | 2015-05-14 | 2016-11-17 | Applied Medical Resources Corporation | Synthetic tissue structures for electrosurgical training and simulation |
| US12512017B2 (en) | 2015-05-27 | 2025-12-30 | Applied Medical Resources Corporation | Surgical training model for laparoscopic procedures |
| WO2016201085A1 (en) | 2015-06-09 | 2016-12-15 | Applied Medical Resources Corporation | Hysterectomy model |
| KR20240128138A (ko) | 2015-07-16 | 2024-08-23 | 어플라이드 메디컬 리소시스 코포레이션 | 시뮬레이션된 절개가능 조직 |
| KR102646090B1 (ko) | 2015-07-22 | 2024-03-12 | 어플라이드 메디컬 리소시스 코포레이션 | 충수절제술 모델 |
| CA3025540A1 (en) | 2015-10-02 | 2017-04-06 | Applied Medical Resources Corporation | Hysterectomy model |
| KR20250016466A (ko) | 2015-11-20 | 2025-02-03 | 어플라이드 메디컬 리소시스 코포레이션 | 시뮬레이션된 절개가능 조직 |
| WO2017165389A2 (en) | 2016-03-24 | 2017-09-28 | Millennium Pharmaceuticals, Inc. | Alginate hydrogel compositions |
| JP6925579B2 (ja) * | 2016-03-31 | 2021-08-25 | 日油株式会社 | 環状ベンジリデンアセタール構造を有する生分解性ヒドロゲル |
| AU2017291422B2 (en) | 2016-06-27 | 2023-04-06 | Applied Medical Resources Corporation | Simulated abdominal wall |
| US12097306B2 (en) * | 2016-12-13 | 2024-09-24 | Takeda Pharmaceutical Company Limited | Conformal coating of biological surfaces |
| JP7235665B2 (ja) | 2017-02-14 | 2023-03-08 | アプライド メディカル リソーシーズ コーポレイション | 腹腔鏡訓練システム |
| US10847057B2 (en) | 2017-02-23 | 2020-11-24 | Applied Medical Resources Corporation | Synthetic tissue structures for electrosurgical training and simulation |
| EP3681636A1 (en) * | 2017-09-11 | 2020-07-22 | Evorion Biotechnologies GmbH | Systems, methods and hydrogels for cell culture and analysis |
| CN108893445A (zh) * | 2018-07-26 | 2018-11-27 | 南方医科大学 | 一种引导视网膜神经节细胞及其轴突生长延展的方法 |
| CN109316628B (zh) * | 2018-09-21 | 2021-04-20 | 广州远想生物科技有限公司 | 一种凝胶及其制备方法和应用 |
| CN109731133B (zh) * | 2019-02-01 | 2020-09-01 | 浙江大学 | 一种抗菌、抗粘附、可注射式温敏壳聚糖凝胶敷料及其制备方法 |
| US11680107B2 (en) * | 2019-03-22 | 2023-06-20 | Taipei Medical University | Hydrogel composition for drug delivery and uses thereof |
| US11807720B2 (en) | 2019-08-28 | 2023-11-07 | Boston Scientific Scimed, Inc. | Multi-armed polyoxazolines and compositions, systems and methods pertaining to the same |
| WO2021138588A1 (en) * | 2020-01-03 | 2021-07-08 | Repertoire Immune Medicines, Inc. | Compositions of hydrogels and methods of use thereof |
| JP2023513175A (ja) * | 2020-02-07 | 2023-03-30 | ザ・ユニバーシティ・オブ・ブリティッシュ・コロンビア | 粘膜付着性ポリマー薬剤供給組成物および方法 |
| CN112898600B (zh) * | 2021-02-07 | 2023-05-23 | 西安工业大学 | 一种聚多巴胺可逆粘附凝胶的分相制备方法 |
| WO2023135155A1 (en) | 2022-01-12 | 2023-07-20 | Eth Zurich | Photocurable phase-separating hydrogels |
| WO2023242189A1 (en) | 2022-06-13 | 2023-12-21 | Eth Zurich | Collagen visualization on microfluidic device |
| EP4616875A1 (en) | 2024-03-12 | 2025-09-17 | Novonexile AG | Semi-interpenetrating polymer networks |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1668697A (zh) * | 2001-11-07 | 2005-09-14 | 苏黎世大学 | 用于控制细胞向内生长和组织再生的合成基质 |
| CN101400327A (zh) * | 2006-03-13 | 2009-04-01 | 凯塞拉生物药品公司 | 流体组织增强组合物和方法 |
| CN102695500A (zh) * | 2009-11-09 | 2012-09-26 | 聚光灯技术合伙有限责任公司 | 多糖基水凝胶 |
| CN103237565A (zh) * | 2010-10-06 | 2013-08-07 | 哈佛学院董事会 | 用于基于材料的细胞疗法的可注射的成孔水凝胶 |
| CN104271638A (zh) * | 2012-03-16 | 2015-01-07 | 本德尔分析控股公司 | 源于亲核活性聚噁唑啉的交联聚合物和医用品 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070264227A1 (en) * | 2001-11-07 | 2007-11-15 | Eidgenossische Technische Hochschule Zurich | Synthetic Matrix for Controlled Cell Ingrowth and Tissue Regeneration |
| BRPI0215192B8 (pt) * | 2001-12-18 | 2021-07-27 | Eidgenoessische Technische Hochschule Zuerich | peptídeo de fusão, kit e matriz que compreendem o mesmo, e método para criar uma matriz |
| AU2003294369B2 (en) * | 2003-01-17 | 2008-08-14 | Cornell Research Foundation, Inc. | Injectable hydrogel microspheres from aqueous two-phase system |
| FR2865737B1 (fr) * | 2004-02-03 | 2006-03-31 | Anteis Sa | Gel reticule biocompatible |
| KR100699278B1 (ko) * | 2005-05-12 | 2007-03-23 | 학교법인 포항공과대학교 | 수화젤레이터로 유용한 바이오틴-아미노산 결합체 및이로부터 제조된 수화젤 |
| KR101551681B1 (ko) * | 2009-07-30 | 2015-09-09 | 카르빌란 테라퓨틱스, 인코포레이티드 | 변형된 히알루론산 폴리머 조성물 및 관련방법 |
| LT2916881T (lt) * | 2012-11-07 | 2020-05-11 | Eth Zurich | Sulfatuoti alginato hidrogeliai, skirti ląstelių kultūrai ir gydymui |
-
2016
- 2016-09-08 EP EP21168993.0A patent/EP3868416B1/en active Active
- 2016-09-08 LT LTEP16763035.9T patent/LT3347061T/lt unknown
- 2016-09-08 DK DK16763035.9T patent/DK3347061T3/da active
- 2016-09-08 CA CA2992692A patent/CA2992692C/en active Active
- 2016-09-08 JP JP2018511412A patent/JP6829898B2/ja active Active
- 2016-09-08 SM SM20210470T patent/SMT202100470T1/it unknown
- 2016-09-08 HR HRP20211306TT patent/HRP20211306T1/hr unknown
- 2016-09-08 EP EP16763035.9A patent/EP3347061B1/en active Active
- 2016-09-08 AU AU2016320395A patent/AU2016320395B2/en active Active
- 2016-09-08 US US15/758,390 patent/US20180264176A1/en not_active Abandoned
- 2016-09-08 RS RS20211024A patent/RS62239B1/sr unknown
- 2016-09-08 DK DK21168993.0T patent/DK3868416T3/da active
- 2016-09-08 WO PCT/EP2016/071238 patent/WO2017042301A1/en not_active Ceased
- 2016-09-08 HU HUE16763035A patent/HUE055937T2/hu unknown
- 2016-09-08 SI SI201631296T patent/SI3347061T1/sl unknown
- 2016-09-08 PT PT167630359T patent/PT3347061T/pt unknown
- 2016-09-08 CN CN201680051583.8A patent/CN108025110B/zh active Active
- 2016-09-08 ES ES16763035T patent/ES2883235T3/es active Active
- 2016-09-08 CN CN202110629796.7A patent/CN113372579B/zh active Active
- 2016-09-08 PL PL16763035T patent/PL3347061T3/pl unknown
-
2018
- 2018-01-18 IL IL257024A patent/IL257024B/en unknown
-
2021
- 2021-08-18 CY CY20211100738T patent/CY1124571T1/el unknown
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1668697A (zh) * | 2001-11-07 | 2005-09-14 | 苏黎世大学 | 用于控制细胞向内生长和组织再生的合成基质 |
| CN101400327A (zh) * | 2006-03-13 | 2009-04-01 | 凯塞拉生物药品公司 | 流体组织增强组合物和方法 |
| CN102695500A (zh) * | 2009-11-09 | 2012-09-26 | 聚光灯技术合伙有限责任公司 | 多糖基水凝胶 |
| CN103237565A (zh) * | 2010-10-06 | 2013-08-07 | 哈佛学院董事会 | 用于基于材料的细胞疗法的可注射的成孔水凝胶 |
| CN104271638A (zh) * | 2012-03-16 | 2015-01-07 | 本德尔分析控股公司 | 源于亲核活性聚噁唑啉的交联聚合物和医用品 |
Also Published As
| Publication number | Publication date |
|---|---|
| CY1124571T1 (el) | 2022-07-22 |
| CN108025110A (zh) | 2018-05-11 |
| IL257024B (en) | 2022-02-01 |
| CN113372579A (zh) | 2021-09-10 |
| EP3347061B1 (en) | 2021-05-19 |
| SI3347061T1 (sl) | 2021-11-30 |
| JP2018535704A (ja) | 2018-12-06 |
| JP6829898B2 (ja) | 2021-02-17 |
| CN113372579B (zh) | 2023-07-14 |
| CA2992692C (en) | 2021-12-21 |
| EP3347061A1 (en) | 2018-07-18 |
| WO2017042301A1 (en) | 2017-03-16 |
| EP3868416B1 (en) | 2022-08-10 |
| RS62239B1 (sr) | 2021-09-30 |
| DK3347061T3 (da) | 2021-08-23 |
| ES2883235T3 (es) | 2021-12-07 |
| HRP20211306T1 (hr) | 2021-11-26 |
| HUE055937T2 (hu) | 2022-01-28 |
| EP3868416A1 (en) | 2021-08-25 |
| DK3868416T3 (da) | 2022-10-31 |
| IL257024A (en) | 2018-03-29 |
| AU2016320395B2 (en) | 2020-09-17 |
| AU2016320395A1 (en) | 2018-02-22 |
| PL3347061T3 (pl) | 2021-11-22 |
| PT3347061T (pt) | 2021-08-25 |
| US20180264176A1 (en) | 2018-09-20 |
| SMT202100470T1 (it) | 2021-09-14 |
| LT3347061T (lt) | 2021-09-10 |
| CA2992692A1 (en) | 2017-03-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN108025110B (zh) | 可注射大孔水凝胶 | |
| US11511016B2 (en) | Method for preparing porous scaffold for tissue engineering, cell culture and cell delivery | |
| Broguiere et al. | Macroporous hydrogels derived from aqueous dynamic phase separation | |
| Lee et al. | Advanced gellan gum-based glycol chitosan hydrogel for cartilage tissue engineering biomaterial | |
| Valmikinathan et al. | Photocrosslinkable chitosan based hydrogels for neural tissue engineering | |
| Yang et al. | Bioinspired poly (γ-glutamic acid) hydrogels for enhanced chondrogenesis of bone marrow-derived mesenchymal stem cells | |
| Costa-Almeida et al. | Microengineered multicomponent hydrogel fibers: combining polyelectrolyte complexation and microfluidics | |
| Fiorica et al. | Hyaluronic acid and beta cyclodextrins films for the release of corneal epithelial cells and dexamethasone | |
| Stewart et al. | Cross-linked hydrogels formed through Diels–Alder coupling of furan-and maleimide-modified poly (methyl vinyl ether-alt-maleic acid) | |
| WO2018197688A1 (en) | Non-covalently assembled conductive hydrogel | |
| Nara et al. | Strategies for faster detachment of corneal cell sheet using micropatterned thermoresponsive matrices | |
| US10682309B2 (en) | Hydrogel microparticle scaffold with gradients of degradability and methods thereof | |
| Kirwale et al. | Chitosan, chondroitin sulfate, and hyaluronic acid based in-situ forming scaffold for efficient cell grafting | |
| Zhang et al. | Enzyme‐assisted activation technique for producing versatile hydrogel microparticle scaffolds with high surface chemical reactivity | |
| Diamond | Decellularized Porcine Brain Matrix for Neural Tissue Engineering | |
| Zhu et al. | Dopamine-functionalized bioinspired pre-chondrogenic hydrogel for cell-free cartilage regeneration | |
| Fernández‐Pérez et al. | Highly Tunable and Cell‐Remodelable Thiol‐ene Alginate‐Peptide Crosslinked Hydrogels to Recreate Cellular and Organoid Microenvironments for Biofabrication | |
| Smith | Cellular hitchhiking via injectable microparticles | |
| ALPES | Hydrogels multi-fonctionnels à base d'acide hyaluronique pour le contrôle de l’adhésion, la prolifération et la différentiation de cellules souches neuronales | |
| WO2025099175A1 (de) | Lebendes kompositmaterial für medizinische produkte |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |